Moderna Hit With Suit Over CureVac COVID Patents
BioNTech subsidiary CureVac has launched a new patent infringement suit against Moderna, claiming its COVID-19 vaccine infringed a handful of patents, saying the Massachusetts-based company "exploited" its messenger RNA technology....To view the full article, register now.
Already a subscriber? Click here to view full article